As of November 12, 2026, MGM-15 (dihydro-7-hydroxymitragynine) is illegal to sell (federally scheduled; state law on file reads gray area) in Pennsylvania. Federal Schedule I (DEA temporary order, drug code 9673), effective 2026-08-26 to 2028-08-26. Controlling source: 35 P.S. 780-102 (designer drug) and 780-113(a)(36) (designer drug offense).
Verified November 12, 2026 (hash check) · confidence: under reviewIs MGM-15 Legal? Every state and federal law
Pennsylvania MGM-15 ban status: ban in force
MGM-15 (dihydro-7-hydroxymitragynine) is not listed in the Pennsylvania schedules (35 P.S. 780-104 and 28 Pa. Code 25.72), and Pennsylvania defines a controlled substance only by reference to the schedules of its own act. Federal scheduling does not carry over automatically: under 35 P.S. 780-103(c) and (d) the Secretary of Health may reschedule to coincide with federal law or temporarily schedule a substance only by publishing a notice in the Pennsylvania Bulletin, and no such notice for 7-OH, MGM-15 or MGM-16 appears in the 2026 Bulletin through the Oct. 24, 2026 issue (the only 2026 scheduling notice extends the nitazene-class temporary scheduling). Pennsylvania has not enacted a kratom consumer protection act; a House bill that would regulate leaf kratom and ban synthetic compounds passed the House in October 2026 and is pending in the Senate, and pending bills do not set status. The remaining state route is the designer-drug offense: 35 P.S. 780-102 defines a designer drug as a substance, other than a controlled substance, intended for human consumption that has a chemical structure or an effect substantially similar to a Schedule I, II or III controlled substance, and 780-113(a)(36) prohibits its manufacture, distribution and possession. A potent mu-opioid agonist sold for human consumption could be charged under the effect prong by comparison with Schedule I or II opioids, but the indole-alkaloid structure is outside the listed example classes and the reach is fact-dependent, so the row is interpretive. Checked: named listing (none), federal incorporation (none automatic; notice required and not published), 7-OH listing with derivative language (none), KCPA synthetic ban (no KCPA enacted), whole-plant ban (none), analog act (designer-drug offense, interpretive). Federal overlay: the compound is federally Schedule I under the DEA temporary order.
"Designer drug" means a substance other than a controlled substance that is intended for human consumption and that either has a chemical structure substantially similar to that of a controlled substance in Schedules I, II or III of this act or that produces an effect substantially similar to that of a controlled substance in Schedules I, II or III. ... (36) The knowing or intentional manufacture, distribution, possession with intent to distribute, or possession of a designer drug.
Among Pennsylvania's 6 neighbors, Delaware, Maryland, New Jersey, New York, Ohio and West Virginia are illegal, the same posture as Pennsylvania.
Open the interactive map · Every compound in Pennsylvania · Where MGM-15 is banned · Embed this map
Federally scheduled or prohibited. Federal Schedule I (DEA temporary order, drug code 9673), effective 2026-08-26 to 2028-08-26 Federal detail
2 instruments on file for this compound’s framework in Pennsylvania; 3 of 3 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
2c48ccb55e535572“Controlled substance” means a drug, substance, or immediate precursor included in
Schedules I through V of this act.
"Cosmetic" means: (i) substances intended to be rubbed, poured, sprinkled or sprayed
on, introduced into or otherwise applied to the human body or other animal body or
any part thereof for cleansing, beautifying, promoting attractiveness or altering
the appearance, and (ii) substances intended for use as a component of any such substances,
except that such term shall not include soap.
"Council" means the Governor’s Council on Drug and Alcohol Abuse.
“Counterfeit” means a controlled substance, other drug, device or cosmetic which,
or the container or labeling of which, without authorization, bears the trademark,
trade name, or other identifying mark, imprint, number, or device, or any likeness
thereof, of a manufacturer, distributor, or dispenser other than the person or persons
who in fact manufactured, distributed, or dispensed such substance and which thereby
is falsely purported or represented to be the product of, or to have been distributed
by, such other manufacturer, distributor, or dispenser.
"Court" means all courts of the Commonwealth of Pennsylvania, including magistrates
and justices of the peace.
"Deliver" or “delivery” means the actual, constructive, or attempted transfer from
one person to another of a controlled substance, other drug, device or cosmetic whether
or not there is an agency relationship.
"Department" means the Department of Health of the Commonwealth of Pennsylvania.
"Designer drug" means a substance other than a controlled substance that is intended
for human consumption and that either has a chemical structure substantially similar
to that of a controlled substance in Schedules I, II or III of this act or that produces
an effect substantially similar to that of a controlled substance in Schedules I,
II or III. Examples of chemical classes in which designer drugs are found include,
but are not limited to, the following: Phenethylamines, N-substituted piperidines,
morphinans, ecgonines, quinazolinones, substituted indoles and arylcycloalkylamines.
(Def. amended Feb. 11, 2000, P.L.9, No.3)
(36) The knowing or intentional manufacture, distribution, possession with intent to distribute,
or possession of a designer drug. Nothing in this section shall be construed to apply
to a person who manufactures or distributes a substance in conformance with the provisions
of an approved new drug application or an exemption for investigational use within
the meaning of section 505 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. §
355). For purposes of this section, no new drug shall be introduced or delivered for
introduction except upon approval of an application pursuant to section 505 of the
Federal Food, Drug and Cosmetic Act. ((36) amended Feb. 11, 2000, P.L.9, No.3)c9fcf559d0254166“Controlled substance” means a drug, substance, or immediate precursor included in Schedules I through V of this act. "Designer drug" means a substance other than a controlled substance that is intended for human consumption and that either has a chemical structure substantially similar to that of a controlled substance in Schedules I, II or III of this act or that produces an effect substantially similar to that of a controlled substance in Schedules I, II or III. Examples of chemical classes in which designer drugs are found include, but are not limited to, the following: Phenethylamines, N-substituted piperidines, morphinans, ecgonines, quinazolinones, substituted indoles and arylcycloalkylamines. (Def. amended Feb. 11, 2000, P.L.9, No.3) Section 13. Prohibited Acts; Penalties.--(a) The following acts and the causing thereof within the Commonwealth are hereby prohibited: (36) The knowing or intentional manufacture, distribution, possession with intent to distribute, or possession of a designer drug. Nothing in this section shall be construed to apply to a person who manufactures or distributes a substance in conformance with the provisions of an approved new drug application or an exemption for investigational use within the meaning of section 505 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. § 355). For purposes of this section, no new drug shall be introduced or delivered for introduction except upon approval of an application pursuant to section 505 of the Federal Food, Drug and Cosmetic Act. ((36) amended Feb. 11, 2000, P.L.9, No.3)
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · RSS · Data licensing · llms.txt · Sitemap